Matthew A. Cunningham

Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial

David M. Brown, David S. Boyer, V. Diana et al. · The Lancet · 2024 · 113 citations

Health Professions, Ophthalmology, Pharmacotherapy +10

Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema

Chirag Jhaveri, Adam R. Glassman, Frederick L. Ferris et al. · New England Journal of Medicine · 2022 · 83 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +15

<p>The Scope Of Three-Dimensional Digital Visualization Systems In Vitreoretinal Surgery</p>

Joshua S. Agranat, John B. Miller, Vivian Paraskevi Douglas et al. · Clinical ophthalmology · 2019 · 68 citations · Full text

Medicine, Ophthalmology, Surgery +15

TSLP and Downstream Molecules in Experimental Mouse Allergic Conjunctivitis

Xiaofen Zheng, Ping Ma, Cintia S. de Paiva et al. · Investigative Ophthalmology & Visual Science · 2010 · 60 citations

Life Sciences, Immunology, Pathobiology +17

Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy

Raj K. Maturi, Adam R. Glassman, Kristin Josic et al. · JAMA · 2023 · 60 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +17